Pfizer relaunches Eliquis to prevent stroke

Saturday, 3 June 2023, 09:33:00
Pfizer has relaunched Eliquis, an anticoagulant to prevent the gradual increase in the prevalence of stroke due to heart condition called atrial fibrillation which is a major concern being a common cause of death among adults. With hypertension as the number one heart disease affecting about 10 million adults in Nigeria and only about one-third […] read more Pfizer relaunches Eliquis to prevent stroke
— BusinessDay

Pfizer’s RSV Vaccine Wins FDA Approval On Heels Of Regulatory Nod For GSK

Saturday, 3 June 2023, 00:03:49
Pfizer’s Abrysvo is now approved for preventing illness caused by respiratory syncytial virus, or RSV, in adults 60 and older. The regulatory decision comes weeks after GSK won approval for its RSV vaccine, Arexvy. The post Pfizer’s RSV Vaccine Wins FDA Approval On Heels Of Regulatory Nod For GSK appeared first on Above the Law .
— MedCity News

3 Undervalued Biotech Stocks to Buy Before They Blast Off

Friday, 2 June 2023, 13:55:32
When investors hear the words “undervalued biotech stocks to buy,” they frequently think of companies in the clinical trial stage. That’s understandable. If you can buy a company’s stock before it releases a game-changing drug or therapeutic into the market, you can make a fortune. That line of thinking was displayed in 2020 when many biotech companies raced to produce a Covid-19 vaccine. But every investor also knows that many of those moonshots never pan out. That’s not the kind of uncertainty you need in this current market. A better option is to look at the companies that already have FDA-approved drugs in the market and a pipeline of potential products on the way. This increases your chance of success. And the good news is that there are several high-potential biotech stocks . By this, I mean the stocks are trading below the average price-to-earnings of the biotech sector, which is around 19x as of this writing. These stocks also have other catalysts that make them compelling stocks to buy.
— InvestorPlace

Nigeria: Pfizer Moves to Check High Prevalence of Stroke in Nigeria

Friday, 2 June 2023, 10:36:49
[Leadership] Pharmaceutical giant, Pfizer has relaunched Eliquis, an anticoagulant, to address the continued increase in the prevalence of stroke due to heart condition called atrial fibrillation in Nigeria which is a common cause of death in the adult population.
— All Africa Global Media

7 Deeply Undervalued Growth Stocks to Buy in June

Friday, 2 June 2023, 02:04:48
Typically, securities may be less appreciated by the market because they stink, which means several proposals for best undervalued growth stocks for June might not make the cut. At the same time, betting on the same ship as everyone else presents its own risks. Namely, you could end up holding the bag. To improve the odds of success for high growth potential stocks for June, investors should first target holistically undervalued entities. In other words, your most viable prospects should be discounted across several metrics, such as earnings, sales and book value. This way, you’re more likely to mitigate the impact of aberrant statistics. Another factor to consider is the fundamentals. Several public firms incur red ink because the narrative appears bearish right now. However, down the line, the framework might change. If you’re willing to speculate on the future, these are the top bargain stocks with growth potential to consider. HF Sinclair (DINO) Source: Tendo / Shutterstock Headquartered in Dallas, Texas, HF Sinclair (NYSE: DINO ) is an independent petroleum refiner and marketer that produces high value light products such as gasoline, diesel fuel, jet fuel and other specialty products.
— InvestorPlace